Benzamide, N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl]-


Chemical Name: Benzamide, N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl]-
CAS Number: 331770-21-9
Product Number: AG01EPC8(AGN-PC-0LUNNG)
Synonyms:
MDL No:
Molecular Formula: C23H20N4O3
Molecular Weight: 400.4299

Identification/Properties


Properties
Form:
Solid
Computed Properties
Molecular Weight:
400.438g/mol
XLogP3:
4.2
Hydrogen Bond Donor Count:
2
Hydrogen Bond Acceptor Count:
6
Rotatable Bond Count:
6
Exact Mass:
400.154g/mol
Monoisotopic Mass:
400.154g/mol
Topological Polar Surface Area:
85.4A^2
Heavy Atom Count:
30
Formal Charge:
0
Complexity:
549
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



Aurora Kinase Inhibitor II is a versatile compound widely utilized in chemical synthesis for its potent inhibitory effects on the Aurora kinases, a group of serine/threonine protein kinases crucial for cell division and proliferation. By specifically targeting these kinases, Aurora Kinase Inhibitor II exerts control over the phosphorylation events that regulate various cellular processes, such as mitosis and the cell cycle. In chemical synthesis, this inhibitor is employed to modulate kinase activity, thus influencing cell growth and division in a controlled manner. Researchers and chemists leverage the precise mechanism of action of Aurora Kinase Inhibitor II to manipulate kinase signaling pathways, explore therapeutic interventions targeting aberrant cell proliferation, and unravel the intricate molecular mechanisms underlying diseases like cancer. Its application in chemical synthesis contributes significantly to advancing our understanding of cellular processes and developing innovative strategies for targeted drug therapies.